Pictet Asset Management (UK)’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$26M Buy
744,897
+47,379
+7% +$1.38M 0.03% 470
2021
Q1
$23.2M Sell
697,518
-385,899
-36% -$13.5M 0.03% 476
2020
Q4
$28.1M Sell
1,083,417
-877,725
-45% -$14.9M 0.04% 420
2020
Q3
$19.4M Buy
1,961,142
+201,185
+11% +$1.16M 0.03% 432
2020
Q2
$6.07M Hold
1,759,957
0.01% 637
2020
Q1
$5.38M Buy
1,759,957
+24,124
+1% +$98.8K 0.01% 625
2019
Q4
$8.92M Buy
1,735,833
+251,961
+17% +$1.28M 0.02% 617
2019
Q3
$7.66M Buy
1,483,872
+1,452,172
+4,581% +$8.12M 0.02% 596
2019
Q2
$192K Buy
+31,700
New +$222K ﹤0.01% 1003

Other funds holding PACB